These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3085563

  • 1. The platelet thromboxane inhibitor, dazmegrel, does not reduce monocrotaline-induced pulmonary hypertension.
    Langleben D, Carvalho AC, Reid LM.
    Am Rev Respir Dis; 1986 May; 133(5):789-91. PubMed ID: 3085563
    [Abstract] [Full Text] [Related]

  • 2. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 3. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

  • 4. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension.
    Kataoka M, Nagaya N, Satoh T, Itoh T, Murakami S, Iwase T, Miyahara Y, Kyotani S, Sakai Y, Kangawa K, Ogawa S.
    Am J Respir Crit Care Med; 2005 Dec 15; 172(12):1575-80. PubMed ID: 16192456
    [Abstract] [Full Text] [Related]

  • 5. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S, Ellinghaus P, Janssen W, Kramer F, Lustig K, Milting H, Kast R, Klein M.
    Cardiovasc Res; 2009 Apr 01; 82(1):30-9. PubMed ID: 19131365
    [Abstract] [Full Text] [Related]

  • 6. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Apr 01; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Thromboxane does not mediate pulmonary vascular response to monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Am J Physiol; 1987 Apr 01; 252(4 Pt 2):H743-8. PubMed ID: 2952022
    [Abstract] [Full Text] [Related]

  • 9. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 10. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
    Ganey PE, Roth RA.
    Toxicol Appl Pharmacol; 1987 Apr 01; 88(2):157-64. PubMed ID: 3564035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
    Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, Rabinovitch M.
    Lab Invest; 1988 Feb 01; 58(2):184-95. PubMed ID: 3123799
    [Abstract] [Full Text] [Related]

  • 15. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U, Olson JW, Gillespie MN.
    Res Commun Chem Pathol Pharmacol; 1988 Nov 01; 62(2):187-94. PubMed ID: 3150791
    [Abstract] [Full Text] [Related]

  • 16. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J, Shimpo H, Shimamoto A, Chong AJ, Hampton CR, Spring DJ, Yada M, Takao M, Onoda K, Yada I, Pohlman TH, Verrier ED.
    J Thorac Cardiovasc Surg; 2004 Dec 01; 128(6):850-9. PubMed ID: 15573069
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
    Yip HK, Chang LT, Sun CK, Sheu JJ, Chiang CH, Youssef AA, Lee FY, Wu CJ, Fu M.
    Crit Care Med; 2008 Mar 01; 36(3):873-80. PubMed ID: 18431275
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, Schudt C, Ermert L, Seeger W, Grimminger F.
    Circ Res; 2004 Apr 30; 94(8):1101-8. PubMed ID: 15031263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.